Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Current Deferred Revenue: 2016-2024

  • Zepp Health's Current Deferred Revenue fell 34.95% to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year decrease of 34.95%. This contributed to the annual value of $4.9 million for FY2024, which is 34.95% down from last year.
  • Latest data reveals that Zepp Health reported Current Deferred Revenue of $4.9 million as of Q4 2024, which was down 34.95% from $7.6 million recorded in Q4 2023.
  • Zepp Health's Current Deferred Revenue's 5-year high stood at $7.6 million during Q4 2023, with a 5-year trough of $309,000 in Q4 2022.
  • Over the past 3 years, Zepp Health's median Current Deferred Revenue value was $4.9 million (recorded in 2024), while the average stood at $4.3 million.
  • As far as peak fluctuations go, Zepp Health's Current Deferred Revenue tumbled by 89.81% in 2021, and later soared by 2,360.52% in 2023.
  • Over the past 5 years, Zepp Health's Current Deferred Revenue (Quarterly) stood at $6.5 million in 2020, then plummeted by 89.81% to $664,000 in 2021, then crashed by 53.46% to $309,000 in 2022, then skyrocketed by 2,360.52% to $7.6 million in 2023, then crashed by 34.95% to $4.9 million in 2024.
  • Its last three reported values are $4.9 million in Q4 2024, $7.6 million for Q4 2023, and $309,000 during Q4 2022.